Compare GMRE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMRE | BME |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Trusts Except Educational Religious and Charitable |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 463.1M | 545.3M |
| IPO Year | N/A | N/A |
| Metric | GMRE | BME |
|---|---|---|
| Price | $36.90 | $42.14 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $40.50 | N/A |
| AVG Volume (30 Days) | ★ 69.7K | 34.0K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 8.17% | 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $144,829,000.00 | N/A |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $3.18 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 6.04 | N/A |
| 52 Week Low | $29.05 | $35.53 |
| 52 Week High | $45.75 | $43.20 |
| Indicator | GMRE | BME |
|---|---|---|
| Relative Strength Index (RSI) | 67.82 | 52.71 |
| Support Level | $33.79 | $41.59 |
| Resistance Level | $35.44 | $42.35 |
| Average True Range (ATR) | 0.77 | 0.51 |
| MACD | 0.12 | -0.06 |
| Stochastic Oscillator | 98.42 | 53.33 |
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.